Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCEED: Paricalcitol in Type 2 Diabetes with Proteinuria
NCT01393808Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Sep 2011
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in proteinuria and diabetic nephropathy (DN) comparing Paricalcitol with Placebo (2 arms). Primary endpoint: Urinary albumin excretion at 4 months. Started Sep 2011; status: completed.
02
Drugs
paricalcitol
03
Conditions
proteinuriadiabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01393808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393808.